From GlobeNewswire: 2024-08-01 02:00:00

The Global Trypsin Market is projected to grow from USD 90.8 million in 2023 to USD 151.6 million by 2033, with a CAGR of 5.26%. Trypsin is a vital enzyme used in protein digestion in the small intestine, playing a crucial role in various sectors such as pharmaceuticals, food science, and environmental research. The bovine segment is expected to dominate the market, offering unique properties for protein hydrolysis.

In the global trypsin market, the biotechnology and pharmaceutical industry segment is forecasted to experience the fastest growth during the projected period. This growth is driven by investments in manufacturing enzymes and proteins, particularly in innovative areas such as biotechnology and pharmaceuticals. The industrial use segment is also expected to grow significantly due to the expanding applications of trypsin in various sectors.

North America is poised to hold the largest share of the global trypsin market over the forecast period, with a high demand for trypsin in diagnostic applications. In contrast, Asia Pacific is expected to exhibit the fastest growth, particularly in South Asia and the Western Pacific regions. The rise in pancreatitis, cystic fibrosis, and cancer cases is contributing to the demand for trypsin in the diagnostic sector.

Key vendors in the global trypsin market include Promega Corporation, Merck KgaA, Thermo Fisher Scientific Inc., and others. Recent developments include advancements in recombinant trypsin chemistry, enhancing reliability and reducing digestion time. The market segmentation is based on type, application, and end-user, with detailed revenue forecasts at global, regional, and country levels from 2020 to 2033. Spherical Insights & Consulting offers comprehensive market research and consulting services to aid decision-makers in various industries.



Read more at GlobeNewswire: Global Trypsin Market Size To Worth USD 151.6 Million By